Global Myasthenia Gravis Treatment Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (Cholinesterase Inhibitors, Corticosteroids, Immunosuppressants, IVIg, and Monoclonal Antibodies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare
RELEASE DATE May 2025
REPORT ID SI11064
PAGES 245
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Drug Class
      2. Market Attractiveness Analysis By Distribution Channel
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Rising unmet needs
    3. Restraints
      1. Limited Patient Population
    4. Opportunities
      1.  Emerging Immunotherapies
    5. Challenges
      1. High Treatment Costs
  6. Global Myasthenia Gravis Treatment Market Analysis and Projection, By Drug Class
    1. Segment Overview
    2. Cholinesterase Inhibitors
    3. Corticosteroids
    4. Immunosuppressants
    5. IVIg
    6. Monoclonal Antibodies
  7. Global Myasthenia Gravis Treatment Market Analysis and Projection, By Distribution Channel
    1. Segment Overview
    2. Hospital Pharmacies
    3. Retail Pharmacies
    4. Online Pharmacies

 

  1. Global Myasthenia Gravis Treatment Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  2. Global Myasthenia Gravis Treatment Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Myasthenia Gravis Treatment Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  3. Company Profiles
    1. AbbVie Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Grifols SA 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Shire plc 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Pfizer, Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Novartis 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  F.Hoffmann-La Roche AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   GlaxoSmithKline Plc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Alexion Pharmaceutical Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Bausch Health Companies Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Avadel Pharmaceuticals, Plc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Others
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Myasthenia Gravis Treatment Market, By Drug Class, 2024-2034(USD Billion)
  2. Global Cholinesterase Inhibitors, Myasthenia Gravis Treatment Market, By Region, 2024-2034(USD Billion)
  3. Global Corticosteroids, Myasthenia Gravis Treatment Market, By Region, 2024-2034(USD Billion)
  4. Global Immunosuppressants, Myasthenia Gravis Treatment Market, By Region, 2024-2034(USD Billion)
  5. Global IVIg, Myasthenia Gravis Treatment Market, By Region, 2024-2034(USD Billion)
  6. Global Monoclonal Antibodies, Myasthenia Gravis Treatment Market, By Region, 2024-2034(USD Billion)
  7. Global Myasthenia Gravis Treatment Market, By Distribution Channel, 2024-2034(USD Billion)
  8. Global Hospital Pharmacies, Myasthenia Gravis Treatment Market, By Region, 2024-2034(USD Billion)
  9. Global Retail Pharmacies, Myasthenia Gravis Treatment Market, By Region, 2024-2034(USD Billion)
  10. Global Online Pharmacies, Myasthenia Gravis Treatment Market, By Region, 2024-2034(USD Billion)
  11. North America Myasthenia Gravis Treatment Market, By Drug Class, 2024-2034(USD Billion)
  12. North America Myasthenia Gravis Treatment Market, By Distribution Channel, 2024-2034(USD Billion)
  13. U.S.  Myasthenia Gravis Treatment Market, By Drug Class, 2024-2034(USD Billion)
  14. U.S.  Myasthenia Gravis Treatment Market, By Distribution Channel, 2024-2034(USD Billion)
  15. Canada Myasthenia Gravis Treatment Market, By Drug Class, 2024-2034(USD Billion)
  16. Canada Myasthenia Gravis Treatment Market, By Distribution Channel, 2024-2034(USD Billion)
  17. Mexico Myasthenia Gravis Treatment Market, By Drug Class, 2024-2034(USD Billion)
  18. Mexico Myasthenia Gravis Treatment Market, By Distribution Channel, 2024-2034(USD Billion)
  19. Europe Myasthenia Gravis Treatment Market, By Drug Class, 2024-2034(USD Billion)
  20. Europe Myasthenia Gravis Treatment Market, By Distribution Channel, 2024-2034(USD Billion)
  21. Germany Myasthenia Gravis Treatment Market, By Drug Class, 2024-2034(USD Billion)
  22. Germany Myasthenia Gravis Treatment Market, By Distribution Channel, 2024-2034(USD Billion)
  23. France Myasthenia Gravis Treatment Market, By Drug Class, 2024-2034(USD Billion)
  24. France Myasthenia Gravis Treatment Market, By Distribution Channel, 2024-2034(USD Billion)
  25. U.K.  Myasthenia Gravis Treatment Market, By Drug Class, 2024-2034(USD Billion)
  26. U.K.  Myasthenia Gravis Treatment Market, By Distribution Channel, 2024-2034(USD Billion)
  27. Italy Myasthenia Gravis Treatment Market, By Drug Class, 2024-2034(USD Billion)
  28. Italy Myasthenia Gravis Treatment Market, By Distribution Channel, 2024-2034(USD Billion)
  29. Spain Myasthenia Gravis Treatment Market, By Drug Class, 2024-2034(USD Billion)
  30. Spain Myasthenia Gravis Treatment Market, By Distribution Channel, 2024-2034(USD Billion)
  31. Asia Pacific Myasthenia Gravis Treatment Market, By Drug Class, 2024-2034(USD Billion)
  32. Asia Pacific Myasthenia Gravis Treatment Market, By Distribution Channel, 2024-2034(USD Billion)
  33. Japan Myasthenia Gravis Treatment Market, By Drug Class, 2024-2034(USD Billion)
  34. Japan Myasthenia Gravis Treatment Market, By Distribution Channel, 2024-2034(USD Billion)
  35. China Myasthenia Gravis Treatment Market, By Drug Class, 2024-2034(USD Billion)
  36. China Myasthenia Gravis Treatment Market, By Distribution Channel, 2024-2034(USD Billion)
  37. India Myasthenia Gravis Treatment Market, By Drug Class, 2024-2034(USD Billion)
  38. India Myasthenia Gravis Treatment Market, By Distribution Channel, 2024-2034(USD Billion)
  39. South America Myasthenia Gravis Treatment Market, By Drug Class, 2024-2034(USD Billion)
  40. South America Myasthenia Gravis Treatment Market, By Distribution Channel, 2024-2034(USD Billion)
  41. Brazil Myasthenia Gravis Treatment Market, By Drug Class, 2024-2034(USD Billion)
  42. Brazil Myasthenia Gravis Treatment Market, By Distribution Channel, 2024-2034(USD Billion)
  43. The Middle East and Africa Myasthenia Gravis Treatment Market, By Drug Class, 2024-2034(USD   Billion)
  44. The Middle East and Africa Myasthenia Gravis Treatment Market, By Distribution Channel, 2024-2034(USD   Billion)
  45. UAE Myasthenia Gravis Treatment Market, By Drug Class, 2024-2034(USD Billion)
  46. UAE Myasthenia Gravis Treatment Market, By Distribution Channel, 2024-2034(USD Billion)
  47. South Africa Myasthenia Gravis Treatment Market, By Drug Class, 2024-2034(USD Billion)
  48. South Africa Myasthenia Gravis Treatment Market, By Distribution Channel, 2024-2034(USD Billion)

List of Figures 

  1. Global Myasthenia Gravis Treatment Market Segmentation
  2. Myasthenia Gravis Treatment Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Myasthenia Gravis Treatment Market
  9. Top Winning Strategies, 2024-2034
  10. Top Winning Strategies, By Development, 2024-2034(%)
  11. Top Winning Strategies, By Company, 2024-2034
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Myasthenia Gravis Treatment Market
  20. Myasthenia Gravis Treatment Market Segmentation, By Drug Class
  21. Myasthenia Gravis Treatment Market For Cholinesterase Inhibitors, By Region, 2024-2034 ($ Billion)
  22.  Myasthenia Gravis Treatment Market For Corticosteroids, By Region, 2024-2034 ($ Billion)
  23. Myasthenia Gravis Treatment Market For Immunosuppressants, By Region, 2024-2034 ($ Billion)
  24. Myasthenia Gravis Treatment Market For IVIg, By Region, 2024-2034 ($ Billion)
  25. Myasthenia Gravis Treatment Market For Monoclonal Antibodies, By Region, 2024-2034 ($ Billion)
  26.  Myasthenia Gravis Treatment Market Segmentation, By Distribution Channel
  27.  Myasthenia Gravis Treatment Market For Hospital Pharmacies, By Region, 2024-2034 ($ Billion)
  28.  Myasthenia Gravis Treatment Market For Retail Pharmacies, By Region, 2024-2034 ($ Billion)
  29. Myasthenia Gravis Treatment Market For Online Pharmacies, By Region, 2024-2034 ($ Billion)
  30. AbbVie Inc.: Net Sales, 2024-2034 ($ Billion)
  31. AbbVie Inc.: Revenue Share, By Segment, 2024 (%)
  32. AbbVie Inc.: Revenue Share, By Region, 2024 (%)
  33. Grifols SA: Net Sales, 2024-2034 ($ Billion)
  34. Grifols SA: Revenue Share, By Segment, 2024 (%)
  35. Grifols SA: Revenue Share, By Region, 2024 (%)
  36. Shire plc: Net Sales, 2024-2034 ($ Billion)
  37. Shire plc: Revenue Share, By Segment, 2024 (%)
  38. Shire plc: Revenue Share, By Region, 2024 (%)
  39. Pfizer, Inc.: Net Sales, 2024-2034 ($ Billion)
  40. Pfizer, Inc.: Revenue Share, By Segment, 2024 (%)
  41. Pfizer, Inc.: Revenue Share, By Region, 2024 (%)
  42. Novartis: Net Sales, 2024-2034 ($ Billion)
  43. Novartis: Revenue Share, By Segment, 2024 (%)
  44. Novartis: Revenue Share, By Region, 2024 (%)
  45. F.Hoffmann-La Roche AG: Net Sales, 2024-2034 ($ Billion)
  46. F.Hoffmann-La Roche AG: Revenue Share, By Segment, 2024 (%)
  47. F.Hoffmann-La Roche AG: Revenue Share, By Region, 2024 (%)
  48. GlaxoSmithKline Plc.: Net Sales, 2024-2034 ($ Billion)
  49. GlaxoSmithKline Plc.: Revenue Share, By Segment, 2024 (%)
  50. GlaxoSmithKline Plc.: Revenue Share, By Region, 2024 (%)
  51. Alexion Pharmaceutical Inc.: Net Sales, 2024-2034 ($ Billion)
  52. Alexion Pharmaceutical Inc.: Revenue Share, By Segment, 2024 (%)
  53. Alexion Pharmaceutical Inc.: Revenue Share, By Region, 2024 (%)
  54. Bausch Health Companies Inc..: Net Sales, 2024-2034 ($ Billion)
  55. Bausch Health Companies Inc..: Revenue Share, By Segment, 2024 (%)
  56. Bausch Health Companies Inc..: Revenue Share, By Region, 2024 (%)
  57. Avadel Pharmaceuticals, Plc.: Net Sales, 2024-2034 ($ Billion)
  58. Avadel Pharmaceuticals, Plc.: Revenue Share, By Segment, 2024 (%)
  59. Avadel Pharmaceuticals, Plc.: Revenue Share, By Region, 2024 (%)
  60. Others: Net Sales, 2024-2034 ($ Billion)
  61. Others: Revenue Share, By Segment, 2024 (%)
  62. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2024
Tables & Figures:122
Pages:245
Countries covered:20
Companies covered::15
Forecast CAGR:7.72%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies